Метаболически-ассоциированная жировая болезнь печени у детей: современный взгляд на патогенез, клинические особенности, методы диагностики и лечения
https://doi.org/10.31146/1682-8658-ecg-229-9-75-85
Аннотация
Об авторах
М. Ю. КомиссароваРоссия
Р. С. Мальцев
Россия
А. М. Филин
Россия
М. М. Алимов
Россия
Н. В. Евдокимова
Россия
В. П. Новикова
Россия
Список литературы
1. Milner E.B., Evdokimova N.V., Novikova V.P. et al. Cardiovascular risks in obese adolescents. Vopr. prakt. pediatr. (Clinical Practice in Pediatrics). 2022; 17(5): 83-89. (In Russ.) doi: 10.20953/1817-7646-2022-5-83-89.@@ Мильнер Е.Б., Евдокимова Н.В., Новикова В.П. и соавт. Кардиоваскулярные риски подросткового ожирения. Вопросы практической педиатрии. 2022. Т. 17, № 5. С. 83-89. doi: 10.20953/1817-7646-2022-5-83-89.
2. Gritsinskaya V.L., Novikova V.P., Khavkin A.I. Epidemiology of obesity in children and adolescents (systematic review and meta-analysis of publications over a 15-year period). Vopr. prakt. pediatr. (Clinical Practice in Pediatrics). 2022; 17(2): 126-135. (In Russ.) doi: 10.20953/1817-7646-2022-2-126-135.@@ Грицинская В.Л., Новикова В.П., Хавкин А.И. К вопросу об эпидемиологии ожирения у детей и подростков (систематический обзор и мета-анализ научных публикаций за 15-летний период). Вопросы практической педиатрии. 2022; 17(2): 126-135. doi: 10.20953/1817-7646-2022-2-126-135.
3. Peterkova V.A., Bezlepkina O.B., Bolotova N.V. et al. Clinical guidelines «Obesity in children». Problems of Endocrinology. 2021;67(5):67-83. (In Russ.) doi: 10.14341/probl12802.@@ Петеркова В.А., Безлепкина О.Б., Болотова Н.В. и соавт. Клинические рекомендации «Ожирение у детей». Проблемы Эндокринологии. 2021;67(5):67-83. doi: 10.14341/probl12802.
4. Multidisciplinary problems of obesity in children / edited by V.P. Novikova, M.M. Gurova. - St. Petersburg: SpetsLit, 2019. - 582 p. (in Russ.)@@ Мультидисциплинарные проблемы ожирения у детей / под ред. В.П. Новиковой, М.М. Гуровой. - Санкт-Петербург: СпецЛит, 2019. - 582 с.
5. Namazova-Baranova L.S., Yeletskaya K.A., Kaytukova E.V. et al. Evaluation of the Physical Development of Children of Secondary School Age: аn Analysis of the Results of a Cross-Sectional Study. Pediatric pharmacology. 2018;15(4):333-342. (In Russ.) doi: 10.15690/pf.v15i4.1948.@@ Намазова-Баранова Л.С., Елецкая К.А., Кайтукова Е.В. и соавт. Оценка физического развития детей среднего и старшего школьного возраста: анализ результатов одномоментного исследования. Педиатрическая фармакология. 2018; 15 (4): 333-342. doi: 10.15690/pf.v15i4.1948.
6. Anderson EL, Howe LD, Jones HE et al. The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis. PLoS One. 2015 Oct 29;10(10): e0140908. doi: 10.1371/journal.pone.0140908.
7. Gastrointestinal tract and obesity in children / ed. V.P. Novikova, M.M. Gurova. - St. Petersburg: SpetsLit, 2016. 302 p. (in Russ.)@@ Желудочно-кишечный тракт и ожирение у детей / под ред. В.П. Новиковой, М.М. Гуровой. - Санкт-Петербург: СпецЛит, 2016. - 302 с.
8. Hegarty R, Kyrana E, Fitzpatrick E et al. Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges. Ther Adv Endocrinol Metab. 2023 Mar 22;14:20420188231160388. doi: 10.1177/20420188231160388.
9. Xing Y., Fan J., Wang H.J. et al.Comparison of MAFLD and NAFLD Characteristics in Children. Children (Basel). 2023 Mar 16;10(3):560. doi: 10.3390/children10030560.
10. Le Garf S., Nègre V., Anty R. et al. Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem. Biomedicines. 2021;9:1915. doi: 10.3390/biomedicines9121915.
11. Lazebnik L.B., Golovanova E.V., Turkina S.V. et al. Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version. Experimental and Clinical Gastroenterology. 2021;1(1):4-52. (In Russ.) doi: 10.31146/1682-8658-ecg-185-1-4-52.@@ Лазебник Л.Б., Голованова Е.В., Туркина С.В. и соавт. Неалкогольная жировая болезнь печени у взрослых: клиника, диагностика, лечение. Рекомендации для терапевтов, третья версия. Экспериментальная и клиническая гастроэнтерология. 2021;185(1): 4-52. doi: 10.31146/1682-8658-ecg-185-1-4-52.
12. Mărginean C.O., Meliț L.E., Săsăran M.O. Metabolic Associated Fatty Liver Disease in Children-From Atomistic to Holistic. Biomedicines. 2021 Dec 9;9(12):1866. doi: 10.3390/biomedicines9121866.
13. Flisiak-Jackiewicz M., Bobrus-Chociej A., Wasilewska N. et al. From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-New Terminology in Pediatric Patients as a Step in Good Scientific Direction? J Clin Med. 2021 Mar 1;10(5):924. doi: 10.3390/jcm10050924.
14. Brecelj J., Orel R. Non-Alcoholic Fatty Liver Disease in Children. Medicina (Kaunas). 2021 Jul 16;57(7):719. doi: 10.3390/medicina57070719.
15. Lee K.C., Wu P.S., Lin H.C. Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis. Clin Mol Hepatol. 2023 Jan;29(1):77-98. doi: 10.3350/cmh.2022.0237.
16. Castillo-Leon E., Cioffi C.E., Vos M.B. Perspectives on youth-onset nonalcoholic fatty liver disease. Endocrinol Diabetes Metab. 2020 Sep 17;3(4): e00184. doi: 10.1002/edm2.184.
17. Chen Y., Wang W., Morgan M.P. et al. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets. Front Endocrinol (Lausanne). 2023 Jun 8;14:1148934. doi: 10.3389/fendo.2023.1148934.
18. Marques P., Francisco V., Martínez-Arenas L. et al. Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease.Int J Mol Sci. 2023 Jan 24;24(3):2313. doi: 10.3390/ijms24032313.
19. Dwi Astarini F., Ratnasari N., Wasityastuti W. Update on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review. Iran Biomed J. 2022 Jul 1;26(4):252-68. doi: 10.52547/ibj.3647.
20. Potoupni V., Georgiadou M., Chatzigriva E. et al. Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis. J Gastroenterol Hepatol. 2021 Nov;36(11):3002-3014. doi: 10.1111/jgh.15631.
21. Ivashkin V.T., Maevskaya M.V., Zharkova M.S. et al. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022;32(4):104-140. (In Russ.) doi: 10.22416/1382-4376-2022-32-4-104-140.@@ Ивашкин В.Т., Маевская М.В., Жаркова М.С. и соавт. Клинические рекомендации Российского общества по изучению печени, Российской гастроэнтерологической ассоциации, Российской ассоциации эндокринологов, Российской ассоциации геронтологов и гериатров и Национального общества профилактической кардиологии по диагностике и лечению неалкогольной жировой болезни печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2022;32(4):104-140. doi: 10.22416/1382-4376-2022-32-4-104-140.
22. Bokova T.A. Non-alcoholic fatty liver disease in children with obesity and metabolic syndrome. The attending physician. 2019;1:28-31. (In Russ.)@@ Бокова Т.А. Неалкогольная жировая болезнь печени у детей с ожирением и метаболическим синдромом. Лечащий врач. 2019;1:28-31.
23. Novikova V.P. Fatty hepatosis in the structure of metabolic syndrome in children. Preventive and clinical medicine St. Petersburg. 2010;(3-4):33-41. (in Russ.)@@ Новикова В.П. Жировой гепатоз в структуре метаболического синдрома у детей // Профилактическая и клиническая медицина. СПб, 2010. - № 3-4. - С 33-41.
24. Chao H.C. Associations among body mass index, abdominal adiposity, and nonalcoholic fatty liver disease in children. Pediatr Neonatol. 2023 Nov;64(6):629-630. doi: 10.1016/j.pedneo.2023.10.001.
25. Vos M.B., Abrams S.H., Barlow S.E. et al. NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):319-334. doi: 10.1097/MPG.0000000000001482.
26. Vajro P., Lenta S., Socha P. et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2012 May;54(5):700-13. doi: 10.1097/MPG.0b013e318252a13f.
27. Giorgio V., Prono F., Graziano F. et al. Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. BMC Pediatr. 2013 Mar 25;13:40. doi: 10.1186/1471-2431-13-40.
28. Yu E.L., Schwimmer J.B. Epidemiology of Pediatric Nonalcoholic Fatty Liver Disease. Clin Liver Dis (Hoboken). 2021 Apr 13;17(3):196-199. doi: 10.1002/cld.1027.
29. Lazebnik L.B., Radchenko V.G., Golovanova E.V. et al. Non-alcoholic fatty liver disease: Clinical picture, diagnosis and treatment (Guidelines for therapists, 2nd version). Experimental and Clinical Gastroenterology. 2017; 138 (2): 22-37. (In Russ.)@@ Лазебник Л.Б., Радченко В.Г., Голованова Е.В. и соавт. Неалкогольная жировая болезнь печени: клиника, диагностика, лечение (Рекомендации для терапевтов, 2-я версия). Экспериментальная и клиническая гастроэнтерология. 2017; 138 (2): 22-37.
30. Ciardullo S., Vergani M., Ronchetti C. et al. Shaping the future of pediatric liver health: unraveling the impact of the new metabolic-associated fatty liver disease definition. Hepatobiliary Surg Nutr 2023;12(4):611-615. doi: 10.21037/hbsn-23-308.
31. Molleston J.P., Schwimmer J.B., Yates K.P. et al. NASH Clinical Research Network. Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels. J Pediatr. 2014 Apr;164(4):707-713.e3. doi: 10.1016/j.jpeds.2013.10.071.
32. Demyanenko A.N., Alimova I.L., Povorova O.V. Early markers of the formation of non-alcoholic fatty liver disease in children with exogenous constitutional obesity.Russian Bulletin of Perinatology and Pediatrics. 2021;66(4):192. (In Russ.)@@ Демяненко А.Н., Алимова И.Л., Поворова О.В. Ранние маркеры формирования неалкогольной жировой болезни печени у детей с экзогенно-конституциональном ожирении // Российский вестник перинатологии и педиатрии. - 2021. - Т. 66, № 4. - С. 192.
33. Jayasekera D., Hartmann P. Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease. World J Hepatol. 2023 May 27;15(5):609-640. doi: 10.4254/wjh.v15.i5.609.
34. Kalashnikova V.A., Novikova V.P., Smirnova N.N. Noninvasive diagnostic method of nonalcoholic fatty liver disease in obese children. Experimental and Clinical Gastroenterology. 2019;168(8): 90-94. (In Russ.) doi: 10.31146/1682-8658-ecg-168-8-90-94.@@ Калашникова В.А., Новикова В.П., Смирнова Н.Н. Неинвазивная диагностика неалкогольной жировой болезни печени у детей с ожирением. 2019;168(8): 90-94. doi: 10.31146/1682-8658-ecg-168-8-90-94.
35. Alkhouri N., Carter-Kent C., Lopez R. et al. A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis. Clin Gastroenterol Hepatol. 2011 Feb;9(2):150-5. doi: 10.1016/j.cgh.2010.09.015.
36. Draijer L.G., van Oosterhout J.P.M., Vali Y. et al. Diagnostic accuracy of fibrosis tests in children with non-alcoholic fatty liver disease: A systematic review. Liver Int. 2021 Sep;41(9):2087-2100. doi: 10.1111/liv.14908.
37. Shirokova E.N., Pavlov C.S., Karaseva A.D. et al. Elastography in the Diagnosis of NonAlcoholic Fatty Liver Disease. Annals of the Russian Academy of Medical Sciences. 2019;74(1):5-13. (In Russ.) doi: 10.15690/vramn1071.@@ Широкова Е.Н., Павлов Ч.С., Карасёва А.Д. и соавт. Эластография в диагностике неалкогольной жировой болезни печени. Вестник РАМН. 2019;74(1):5-13. doi: 10.15690/vramn1071.
38. Yang L., Zhu Y., Zhou L et al. Transient Elastography in the Diagnosis of Pediatric Non-alcoholic Fatty Liver Disease and Its Subtypes. Front Pediatr. 2022 Mar 30;10:808997. doi: 10.3389/fped.2022.808997.
39. Dezsőfi A., Baumann U., Dhawan A. et al.; ESPGHAN Hepatology Committee. Liver biopsy in children: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2015 Mar;60(3):408-20. doi: 10.1097/MPG.0000000000000632.
40. Evdokimova N.V., Shogiradze L.D., Pokhlebkina A.A. et al. Genetic determinants of obesity in adolescent girls.Russian Bulletin of Perinatology and Pediatrics. 2024;69(2):65-71. (In Russ.) doi: 10.21508/1027-4065-2024-69-2-65-71.@@ Евдокимова Н.В., Шогирадзе Л.Д., Похлебкина А.А. и соавт. Генетические детерминанты ожирения у девочек-подростков. Российский вестник перинатологии и педиатрии. 2024;69(2):65-71. doi: 10.21508/1027-4065-2024-69-2-65-71.
41. Rong L., Zou J., Ran W. et al. Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD). Front Endocrinol (Lausanne). 2023 Jan 16;13:1087260. doi: 10.3389/fendo.2022.1087260.
42. Hassani Zadeh S., Mansoori A., Hosseinzadeh M. Relationship between dietary patterns and non-alcoholic fatty liver disease: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2021 Jun;36(6):1470-1478. doi: 10.1111/jgh.15363.
43. Akbulut U.E., Isik I.A., Atalay A. et al. The effect of a Mediterranean diet vs. a low-fat diet on non-alcoholic fatty liver disease in children: a randomized trial.Int J Food Sci Nutr. 2022 May;73(3):357-366. doi: 10.1080/09637486.2021.1979478.
44. Yurtdaş G., Akbulut G., Baran M. et al. The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non-alcoholic fatty liver disease: A randomized controlled trial. Pediatr Obes. 2022 Apr;17(4): e12872. doi: 10.1111/ijpo.12872.
45. Dionysopoulos G., Kalopitas G., Vadarlis A. et al. Can omega-3 fatty acids be beneficial in pediatric NAFLD? A systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2023;63(27):8545-8553. doi: 10.1080/10408398.2022.2062589.
46. Wang J.S., Liu J.C.Intestinal microbiota in the treatment of metabolically associated fatty liver disease. World J Clin Cases. 2022 Nov 6;10(31):11240-11251. doi: 10.12998/wjcc.v10.i31.11240.
47. European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016 Jun;64(6):1388-402. doi: 10.1016/j.jhep.2015.11.004.
48. Chalasani N., Younossi Z., Lavine J.E. et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367.
49. Pratt J.S.A., Browne A., Browne N.T. et al. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg Obes Relat Dis. 2018 Jul;14(7):882-901. doi: 10.1016/j.soard.2018.03.019.
50. Chauhan M., Singh K., Thuluvath P.J. Bariatric Surgery in NAFLD. Dig Dis Sci. 2022 Feb;67(2):408-422. doi: 10.1007/s10620-021-07317-3.
51. Manco M., Mosca A., De Peppo F. et al. The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis. J Pediatr. 2017 Jan;180:31-37.e2. doi: 10.1016/j.jpeds.2016.08.101.
52. Lassailly G., Caiazzo R., Ntandja-Wandji L.C. et al. Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis. Gastroenterology. 2020 Oct;159(4):1290-1301.e5. doi: 10.1053/j.gastro.2020.06.006.
Рецензия
Для цитирования:
Комиссарова М.Ю., Мальцев Р.С., Филин А.М., Алимов М.М., Евдокимова Н.В., Новикова В.П. Метаболически-ассоциированная жировая болезнь печени у детей: современный взгляд на патогенез, клинические особенности, методы диагностики и лечения. Экспериментальная и клиническая гастроэнтерология. 2024;(9):75-85. https://doi.org/10.31146/1682-8658-ecg-229-9-75-85
For citation:
Komissarova M.Yu., Maltsev R.S., Filin A.M., Alimov M.M., Evdokimova N.V., Novikova V.P. Metabolic-associated fatty liver disease in children: a modern view of the pathogenesis, clinical features, methods of diagnosis and treatment. Experimental and Clinical Gastroenterology. 2024;(9):75-85. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-229-9-75-85